688221 Share Price Performance
CN¥0
-20.57 (-100.00%)
Price CN¥0
Share Pricen/a
Frontier Biotechnologies Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
688221 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Frontier Biotechnologies Inc. Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 31, 2026
- 0.0092
- 78.60%
- 0.88%
- 42.5%
About 688221
- Founded
- 2002
- Employees
- 314
- CEO
- WebsiteView website
Frontier Biotechnologies Inc., a commercial-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes various medicines that improve patients’ health in China. It offers Aikening, an IV fusion inhibitor for dual therapy of HIV-1. The company’s pipeline products include FB2004 indicated for HBV; FB7011 and FB7013 for IgA nephropathy; FB7012 to treat hyperuricemia and gout; FB7041 to treat tumors; FB7024 for the treatment of hyperlipidemia; FB7023 to treat ASCVD; FB7033 for the treatment of MASH; FB4001 for osteoporosis; and FB3002 for pain management. Frontier Biotechnologies Inc. was founded in 2002 and is headquartered in Nanjing, China.
